Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 113, Issue 1, 2004, Pages 21-25

  Aydin, Seval ^a   Benian, Ali ^a   Madazli, Riza ^a   Uludaǧ, Seyfettin ^a   Uzun, Hafize ^a   Kaya, Safiye ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

ET 1; Fibronectin; MDA; NO; SE selectin; SOD

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; FIBRONECTIN; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; ASSOCIATION; CASE CONTROL STUDY; CLINICAL ARTICLE; COLORIMETRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS; HUMAN; LIPID PEROXIDATION; NEPHELOMETRY; PLASMA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZATION; SOLUBILITY; STATISTICAL SIGNIFICANCE;

EID: 1442286434     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00368-3     Document Type: Article

References (25)

1. Roborts J.M., Roberts N.T., Musci T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161:1989;1200-1204.
2. Madazli R., Budak E., Calay Z., Aksu M.F. Correlation between placental bed biopsy findings. Br. J. Obstet. Gynecol. 107:2000;514-518.
3. Hubel C.A., Roberts J.M., Taylor R.N.et al. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am. J. Obstet. Gynecol. 161:1989;1025-1034.
4. Stubbs T.M., Lazarchick J., Horger E.O. Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. Am. J. Obstet. Gynecol. 150:1984;885-887.
5. Lyall Harlan JM, Liu DY. Adhesion its role in inflammatory disease. New York: W.H. Freeman & Co.; 1992.
6. Uotila J.T., Tuimala R.J., Aarnio T.M., Pyykko K.A., Ahotupa M.O. Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. Br. J. Obstet. Gynecol. 100(3):1993;270-276.
7. Poranen A.K., Ekblad U., Uotila P., Ahotupa M. Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies. Placenta. 17(7):1996;401-405.
8. American College of Obstetricians and Gynecologists. Management of Preeclampsia. Technical Bulletin No. 91. Washington, DC: American College of Obstetricians and Gynecologists; 1986.
9. Angel M.F., Ramasastry S.S., Swartz Wm.et al. The critical relationship between free radicals and degrees of ischemia: evidence or tissue intolerance of marginal perfusion. Plastic Reconstruct. Surg. 81:1988;233-259.
10. Sun Y., Oberley L.W., Ying L. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34:1988;497-500.
11. Porstmann T., Kiessig S.T. Enzyme immuno-assay techniques. An overview. J. Immunol. Methods. 150:1992;5-21.
12. 15 N nitrate in biological fluids Anal. Biochem. 126:1982;131-138.
13. Cheeseman K.H., Slater T.F. An introduction to free radical biochemistry. Br. Med. Bull. 49:1993;481-493.
14. Fickling S.A., Whitley G.S., Nussey S.S. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leukocyte activation? Br. J. Obstet. Gynaecol. 102:1995;173-174. [letter; comment].
15. Krauss T., Kuhn W., Lakoma C., Augustin H.G. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for the development of preeclampsia. Am. J. Obstet. Gynecol. 177:1997;443-449.
16. Djurovic S., Schjetlein R., Wisloff F., Haugen G., Berg K. Increased levels of intercellular adhesion molecules and vascular cell adhesion molecules in pre-eclampsia. Br. J. Obstet. Gynaecol. 104:1997;466-470.
17. Blann A.D., Tse W., Maxwell S.J., Waite M.A. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J. Hypertens. 12:1994;925-928.
18. Lockwood C.J., Peters J.H. Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia. Am. J. Obstet. Gynecol. 162:1990;358-362.
19. Branch D.W., Dudley D.J., Mitchell M.D. Preliminary evidence for homeostatic mechanism regulating endothelin production in pre-eclampsia. Lancet. 337:1991;943-945.
20. Koyama H., Nishizawa Y., Morii H., Tabata T., Inoue T., Yamaji T. Plasma endothelin levels in patients with uremia. Lancet. i:1989;991-992.
21. Cernacek P., Stewart D.J. Immunoreactive endothelin in human plasma: marked elevation in patients with cardiogenic shock. Biochem. Biophys. Res. Commun. 161:1989;562-567.
22. Seligman S P., Buyon J.P., Clancy R.M., Young B.K., Abramson S.B. The role of nitric oxide in the pathogenesis of pre-eclampsia. Am. J. Obstet. Gynecol. 171:1994;944-948.
23. Silver R.K., Kupferminc M.J., Russell T.L., Adler L., Mullen T.A., Caplan M.S. Evaluation of nitric oxide as a mediator of severe preeclampsia. Am. J. Obstet. Gynecol. 175:1996;1013-1017.
24. Smarason A.K.,.Allman K.G., Young D., Redman C.W. Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with pre-eclampsia. Br. J. Obstet. Gynaecol. 104:1997;538-543.
25. Benedetto C., Marozio L., Neri I., Giarola M., Volpe A., Facchinetti F. Increased L-citrulline/L-arginine plasma ratio in severe preeclampsia. Obstet. Gynecol. 96:2000;395-399.